Effect of renal denervation on coronary flow reserve in patients with resistant hypertension

Clinical Physiology and Functional Imaging
Sebastian VölzSara Svedlund

Abstract

Renal denervation (RDN) is a potential modality in the treatment of patients with resistant hypertension (RH) and has shown beneficial effect on a variety of cardiovascular surrogate markers. Coronary flow reserve, as assessed by transthoracic Doppler echocardiography (TDE-CFR) is impaired in patients with hypertension and is an independent predictor of cardiac morbidity. However, data on the effect of RDN on TDE-CFR are scarce. The main objective of this study was to assess the effect of RDN on TDE-CFR. Twenty-six consecutive patients with RH (9 female and 17 male; mean age 62 ± 8 years; mean number of antihypertensive drugs 4·2 ± 1·6) underwent bilateral RDN. CFR was assessed at baseline and 6 months after intervention. Mean flow velocity was measured in the left anterior descending artery by transthoracic Doppler echocardiography at baseline and during adenosine infusion (TDE-CFR). Systolic office blood pressure was reduced at follow-up (174 ± 24 versus 162 ± 27 mmHG; P = 0·01). Mean systolic ambulatory blood pressure decreased from 151 ± 21 to 147 ± 18 (P = 0·17). TDE-CFR remained unchanged 6 months after intervention (2·7 ± 0·6 versus 2·7 ± 0·7; P = 0·67). In conclusion, renal denervation was not associated with any change...Continue Reading

References

Nov 18, 2004·JAMA : the Journal of the American Medical Association·Peter M OkinUNKNOWN LIFE Study Investigators
Sep 3, 2011·Journal of the American College of Cardiology·Christian UkenaMichael Böhm
Aug 18, 2012·JACC. Cardiovascular Imaging·Anderson C ArmstrongJoão A C Lima
Oct 16, 2012·Journal of the American College of Cardiology·Mathias C BrandtUta C Hoppe
Nov 17, 2012·JACC. Cardiovascular Imaging·Lauro CortigianiRosa Sicari
Jan 15, 2013·Journal of the American College of Cardiology·Ann WittfeldtLi-Ming Gan
May 24, 2013·Journal of Hypertension·Dagmara HeringMarkus P Schlaich
Jun 14, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Joost Daemen
Sep 14, 2013·Journal of Hypertension·Eoin O'BrienUNKNOWN European Society of Hypertension Working Group on Blood Pressure Monitoring
Sep 27, 2013·Journal of Human Hypertension·A PersuUNKNOWN European Network COordinating research on Renal Denervation (ENCOReD)
Apr 1, 2014·The New England Journal of Medicine·Deepak L BhattUNKNOWN SYMPLICITY HTN-3 Investigators
Jun 4, 2014·JAMA : the Journal of the American Medical Association·Wanpen Vongpatanasin
Dec 3, 2014·International Journal of Cardiology·Guido GrassiGiuseppe Mancia
Oct 24, 2015·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Luca DonazzanMichael Böhm
Oct 18, 2016·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Sebastian VölzBengt Rundqvist
Dec 7, 2017·Journal of Hypertension·Sebastian VölzBert Andersson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.